Accolade (ACCD) and Transcarent announced the expiration of the waiting period under the Hart-Scott-Rodino, or HSR, Antitrust Improvements Act of 1976 with respect to the previously announced merger between the two companies. The transaction remains on track to be completed in Q2, subject to Accolade stockholder approval and satisfaction of other customary closing conditions.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACCD:
- Accolade’s Merger Agreement with Transcarent Poses Strategic and Financial Risks
- Etsy upgraded, Pinterest downgraded: Wall Street’s top analyst calls
- Accolade downgraded to Hold from Buy at Truist
- Accolade downgraded to Equal Weight from Overweight at Stephens
- Options Volatility and Implied Earnings Moves Today, January 09, 2025